GHRH analog comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-11-21. Where a claim depends on a specific study, the study is described rather than over-claimed.
The native hormone is produced in the hypothalamus and acts on the anterior pituitary. Binding of GHRH to its receptor stimulates synthesis and release of growth hormone into circulation. Because the analogue retains the receptor-binding region of the parent sequence, it engages the same receptor and triggers the same downstream signaling. The result is increased growth hormone secretion from pituitary cells, which in turn influences hepatic production of insulin-like growth factor 1. This axis is the basis for the compound's measured biological effects.
Interest in this peptide developed because native GHRH has a short circulating lifetime. The N-terminal modification slows cleavage by dipeptidyl peptidase IV, an enzyme that removes the first two residues of many peptides and terminates their activity. Slower degradation means a longer window of receptor stimulation per administration. This design logic parallels other modified peptide hormones, where a small chemical change at a vulnerable site yields a more durable molecule without altering the core mechanism of action.
The peptide is synthesized chemically rather than extracted from biological sources. Solid-phase synthesis builds the chain from the C-terminus toward the N-terminus, after which the hexenoyl group is attached. Purity is typically assessed by high-performance liquid chromatography, and identity is confirmed by mass spectrometry. Regulatory review of the finished product focuses on these analytical controls, since small deviations in sequence or modification can change biological activity. Questions about long-term effects on the pituitary axis remain areas of continued investigation.
Tesamorelin binds the growth hormone–releasing hormone receptor on pituitary somatotroph cells. The receptor signals through the Gs protein, raising intracellular cAMP and activating protein kinase A. That cascade triggers release of stored growth hormone in pulses rather than a steady stream. Because the drug acts at the receptor that normally controls this process, its effect depends on the body's own signaling architecture rather than on a synthetic pathway. The resulting hormone profile reflects the timing of each pulse, not only its size.
Measured responses usually involve growth hormone and insulin-like growth factor 1, known as IGF-1. Growth hormone rises in bursts and is difficult to sample reliably, while IGF-1 shifts more slowly and can be assessed from a single blood draw. Studies therefore treat IGF-1 as the more practical pharmacodynamic marker. Both are indirect, showing that the receptor was engaged rather than that the peptide reached a particular concentration. Direct exposure measurement requires an assay aimed at the molecule itself.
Published work tends to frame tesamorelin as a tool for studying the GHRH axis and as a compound with measurable effects on body composition. Reports often describe visceral adipose tissue as an endpoint, assessed by imaging rather than by inference. Analytical sections commonly describe liquid chromatography with tandem mass spectrometry to confirm identity and purity, because immunoassays may cross-react with related fragments. Where results diverge between studies, differences in assay choice, sampling timing, and population are frequent explanations offered. Whether effects persist after treatment stops remains an open question.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C221H366N72O67S | Reflects a 44-residue peptide with one N-terminal modification |
| Approximate molecular weight | 5136 Da | Sequence length and single acyl group determine the mass |
| Appearance | White to off-white lyophilized powder | Typical form of a purified synthetic peptide |
| Solubility class | Soluble in water and aqueous buffer | Peptide backbone favors aqueous dissolution |
| Common synonyms | GHRH(1-44) analogue; Egrifta | Descriptive name and approved brand name |
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
After injection, the peptide binds receptors on somatotroph cells in the anterior pituitary. Receptor activation raises intracellular cyclic AMP and triggers release of stored growth hormone into the bloodstream. Because the compound works through the body's own regulatory system, growth hormone pulses retain much of their normal feedback control. Repeated administration also raises insulin-like growth factor 1, a hormone produced mainly in the liver. Investigators treat that rise as a marker that the pituitary axis has been engaged.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin acts on the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in intracellular cyclic AMP, which in turn opens ion channels and raises calcium concentrations, leading to release of stored growth hormone into the bloodstream. Because the peptide works through the same receptor as the body's own GHRH, the resulting secretion follows a pulsatile pattern rather than a continuous elevation. The N-terminal modification slows enzymatic breakdown, so the signal persists longer than it would with the unmodified hormone.
Growth hormone released from the pituitary stimulates the liver and other tissues to produce insulin-like growth factor 1, a stable circulating protein that serves as a practical marker of activity. Clinical studies therefore track IGF-1 concentrations alongside the hormone itself, and they commonly measure body composition with imaging rather than relying on body weight alone. Visceral adipose tissue, the fat surrounding abdominal organs, is quantified by computed tomography in the studies that supported approval. Adverse effects reported in trials include injection-site reactions, joint pain, and increases in blood glucose, which is why monitoring accompanies use.
特沙莫瑞林是一种合成肽，其序列与人生长激素释放激素的 44 个氨基酸形式相关。它在 N 端带有反式-3-己烯酰基修饰，这一改动可减缓二肽基肽酶 IV 的降解。该化合物属于生长激素释放激素受体激动剂，可刺激垂体释放生长激素。研究文献通常将其归入合成肽类药物，而非小分子化合物。
监管记录显示，特沙莫瑞林于 2010 年在美国首次获得批准，用于人类免疫缺陷病毒感染相关的脂肪营养不良患者。批准依据来自降低内脏脂肪的临床试验，而非体重或瘦体重的普遍改善。后续出现了不同制剂版本，但其核心适应症保持一致。关于长期心血管结局和死亡率影响，现有证据仍不充分。
Starting from the 1990s, major discoveries of exceptionally preserved fossils in deposits known as conservation Lagerstätten contributed to research on dinosaur soft tissues. Chiefly among these were the rocks that produced the Jehol (Early Cretaceous) and Yanliao (Mid-to-Late Jurassic) biotas of northeastern China, from which hundreds of dinosaur specimens bearing impressions of feather-like structures (both closely related to birds and otherwise, see § Origin of birds) have been described by Xing Xu and colleagues. In living reptiles and mammals, pigment-storing cellular structures known as melanosomes are partially responsible for producing colouration. Both chemical traces of melanin and characteristically shaped melanosomes have been reported from feathers and scales of Jehol and Yanliao dinosaurs, including both theropods and ornithischians. This has enabled multiple full-body reconstructions of dinosaur colouration, such as for Sinosauropteryx and Psittacosaurus by Jakob Vinther and colleagues, and similar techniques have also been extended to dinosaur fossils from other localities. (However, some researchers have also suggested that fossilized melanosomes represent bacterial remains.) Stomach contents in some Jehol and Yanliao dinosaurs closely related to birds have also provided indirect indications of diet and digestive system anatomy (e.g., crops). More concrete evidence of internal anatomy has been reported in Scipionyx from the Pietraroja Plattenkalk of Italy. It preserves portions of the intestines, colon, liver, muscles, and windpipe.
==== Johnson v. Zuffa ==== Based on court filings from late July 2025, the Johnson v. Zuffa antitrust lawsuit, originally filed in 2021, is proceeding, and status conference for the case is scheduled for late August 2025.
In most organisms non-coding genes (ncRNA) are transcribed as precursors that undergo further processing. In the case of ribosomal RNAs (rRNA), they are often transcribed as a pre-rRNA that contains one or more rRNAs. The pre-rRNA is cleaved and modified (2′-O-methylation and pseudouridine formation) at specific sites by approximately 150 different small nucleolus-restricted RNA species, called snoRNAs. SnoRNAs associate with proteins, forming snoRNPs. While snoRNA part basepair with the target RNA and thus position the modification at a precise site, the protein part performs the catalytical reaction. In eukaryotes, in particular a snoRNP called RNase, MRP cleaves the 45S pre-rRNA into the 28S, 5.8S, and 18S rRNAs. The rRNA and RNA processing factors form large aggregates called the nucleolus. In the case of transfer RNA (tRNA), for example, the 5′ sequence is removed by RNase P, whereas the 3′ end is removed by the tRNase Z enzyme and the non-templated 3′ CCA tail is added by a nucleotidyl transferase. In the case of micro RNA (miRNA), miRNAs are first transcribed as primary transcripts or pri-miRNA with a cap and poly-A tail and processed to short, 70-nucleotide stem-loop structures known as pre-miRNA in the cell nucleus by the enzymes Drosha and Pasha. After being exported, it is then processed to mature miRNAs in the cytoplasm by interaction with the endonuclease Dicer, which also initiates the formation of the RNA-induced silencing complex (RISC), composed of the Argonaute protein.
Sources: en.wikipedia.org
{\displaystyle {\begin{cases}\rho {\dfrac {\partial \mathbf {u} }{\partial t}}+\rho (\mathbf {u} \cdot \nabla )\mathbf {u} -\nabla \cdot {\boldsymbol {\sigma }}(\mathbf {u} ,p)=\mathbf {f} &{\text{ in }}\Omega \times (0,T)\\\nabla \cdot \mathbf {u} =0&{\text{ in }}\Omega \times (0,T)\\\mathbf {u} =\mathbf {g} &{\text{ on }}\Gamma _{D}\times (0,T)\\{\boldsymbol {\sigma }}(\mathbf {u} ,p){\hat {\mathbf {n} }}=\mathbf {h} &{\text{ on }}\Gamma _{N}\times (0,T)\\\mathbf {u} (0)=\mathbf {u} _{0}&{\text{ in }}\Omega \times \{0\}\end{cases}}}
As the Southern Operations Room advanced in the suburbs of Damascus, the Syrian Free Army was reported closing in on the capital from the north, after taking control of Palmyra, as well as Darayya. The Republican Guard, traditionally tasked with protecting the Syrian government, did not organize any defenses of Damascus and offered no resistance to the rebel advances. According to The Guardian, videos showed Syrian police and army forces removing their uniforms in the streets of Damascus and an Associated Press journalist reported seeing armed residents along the roads in Damascus's outskirts and finding the city's main police headquarters abandoned. Tank movements were reported in central squares of the capital, while calls of "God is great" rang out from mosques. Even as the situation in Damascus deteriorated, Assad reportedly pretended to work as usual, though he made no effort to organize a last stand or publicly inspire confidence among his loyalists. Syrian state media officially denied allegations that he had fled the capital. In the evening, Assad met with thirty army and security chiefs at the Ministry of Defense, and urged them to keep resisting the insurgents as Russian support was on its way. At 10:30 pm, the president received a phone call by his prime minister Mohammad Ghazi al-Jalali who informed him that the government's situation had further declined, with large numbers of refugees fleeing from Homs toward Latakia. Assad just told him "Tomorrow, we will see. Tomorrow, tomorrow," ending the call.
The Ba'athist government of Syria ruled by the Al-Assad family was known for its extensive involvement in drug trade since the 1970s. As of 2022, the Syrian government financed the biggest multi-billion dollar drug trade in the world, mostly focused on an illegal drug known as Captagon, making it the world's largest narco-state. Its revenues from Captagon smuggling alone were estimated at $57 billion annually in 2022, which is approximately thrice the total trade of all Mexican cartels. General Maher al-Assad, younger brother of Syrian dictator Bashar al-Assad and commander of the Fourth Armoured Division, directly supervised the production, smuggling and profiteering of the drug business. Already suffering from severe financial problems as a result of corruption and civil war, profits from Captagon were said to be the "lifeline" of the Assad regime, through which it earned more than 90% of its total revenue. The smugglers receive direct training from the Syrian military to successfully conduct trafficking operations. Republican Guard, commanded by Maher al-Assad was one of the main Ba'athist military divisions that was engaged in perpetrating brutal crackdowns and mass violence against protestors across the country. In 2018, Bashar al-Assad assigned Maher as the commander of the 4th Armoured Division, a military unit that supervised the Assad regime's criminal enterprises like smuggling, drug trafficking, narcotics production and plunder of goods and resources.
Sources: en.wikipedia.org
=== Fourth wave (2016–present) === The fourth wave, which began in 2016, is characterized by polysubstance use and increased use of stimulants like methamphetamines and cocaine. Additionally, this wave is characterized by the emergence of novel adulterants, such as xylazine and more recently medetomidine in the fentanyl supply. The availability and use of illicit fentanyl continue to be the leading cause of fatalities, but the recent rise of polysubstance use, defined as the practice of using multiple drugs at once or in succession, and stimulants, is linked to the increased fatality rate with the ongoing opioid epidemic. Between 2012 and 2018, there was a threefold increase in mortality related to cocaine use, and a fivefold increase in mortality related to psychostimulants like methamphetamine. This increase has primarily been observed in male populations from non-Hispanic American Indian, non-Hispanic Black, and non-Hispanic White populations. Researchers attribute the increase in illicit drug use to the CDC's recommendations to reduce opioid use through measures like tapering opioid prescribing. In 2023, opioid deaths began a sustained decline after peaking at 73,000 that year. Deaths declined by over 1/3 in 2024. The decline is attributed to the reduced availability of fentanyl precursors from China, as the quality of fentanyl decline along supply chains affecting production in both Mexico and China.
=== Physical characteristics === Wound dressings should be stretchable to prevent tearing. Hai Lei et al. demonstrated that poor elasticity and hysteresis in naturally-derived protein-based hydrogels can be remedied by the addition of polyprotein cross-linkers. The flexibility of hydrogels can also be enhanced by incorporating microgels into the matrix. Hydrogel dressings mimic the fibrous nature of native ECM to maintain cell-to-cell communication at the wound bed for tissue regeneration. Self-healing hydrogels automatically and reversibly repair damage done due to mechanical and chemical stress. Self-healing mechanisms can involve "dynamic covalent bonding, non-covalent interactions", and mixed interactions. Covalent interactions involved in self-healing include Schiff base formation and disulfide exchange. Non-covalent interactions are generally less stable and make the hydrogel more sensitive to microenvironmental changes (e.g. pH, temperature). Some hydrogel dressings are self-healing due to mixed mechanisms such as host-guest and protein-ligand interactions. Hydrogel dressings are available in sheet, amorphous, impregnated, or sprayable forms. Sheet-form hydrogel dressings are non-adhesive against the wound and are effective in healing partial-thickness wounds. Amorphous hydrogels are more effective than sheet-form dressings in treatment of full-thickness wounds because they can conform to the shape of the wound bed and facilitate autolytic debridement. Impregnated hydrogel dressings are dry dressings (e.g. gauzes) saturated with an amorphous hydrogel.
== Applications == Bayesian Inference has extensively been used by molecular phylogeneticists for a wide number of applications. Some of these include: Inference of phylogenies. Inference and evaluation of uncertainty of phylogenies. Inference of ancestral character state evolution. Inference of ancestral areas. Molecular dating analysis. Model dynamics of species diversification and extinction Elucidate patterns in pathogens dispersal. Inference of phenotypic trait evolution.
Sources: en.wikipedia.org
It shares the 44-residue sequence of human GHRH but carries an added trans-3-hexenoyl group at its N-terminus. That addition does not occur in the natural hormone and serves mainly to resist enzymatic breakdown. The receptor target and signaling pathway remain the same.
It binds the growth hormone-releasing hormone receptor on anterior pituitary cells. Activation of that receptor promotes synthesis and release of growth hormone. The effect propagates through the growth hormone and insulin-like growth factor 1 axis.
Native GHRH is cleared quickly by peptidases, which limits how long it can stimulate its receptor. The added group hinders one of the primary cleavage enzymes. The practical consequence is a longer period of receptor activity per dose.
It acts on the growth hormone–releasing hormone receptor, a Gs-coupled receptor found on pituitary somatotroph cells. Activation raises cAMP and prompts pulsatile hormone release.